Market Outlook
By 2035, the US Coronary Stent Devices Market is projected to reach approximately USD 14.92 billion, growing at a CAGR of 6.84% during the forecast period 2026–2035. The market was valued at USD 7.82 billion in 2025, with historical analysis conducted from 2021 to 2024.
The United States remains one of the largest global markets for coronary stent devices due to high cardiovascular disease prevalence, advanced interventional cardiology infrastructure, and strong reimbursement support under Medicare and private insurance programs. Coronary artery disease continues to be the leading cause of death nationwide, with over 800,000 myocardial infarctions occurring annually. Percutaneous coronary intervention (PCI), supported by stent implantation, remains the standard of care for revascularization in both acute and elective settings.
Technological advancements in drug-eluting stents (DES), thinner strut platforms, improved polymer coatings, and next-generation bioresorbable scaffolds are transforming treatment outcomes. Additionally, radial access procedures and outpatient PCI growth are influencing product demand patterns. With increasing aging demographics and rising lifestyle-related risk factors, the US Coronary Stent Devices Market is positioned for steady expansion through 2035.
Introduction
According to the US Coronary Stent Devices Market Report, this sector represents a critical component of interventional cardiology practice in the United States. Coronary stents are small mesh-like devices implanted into narrowed or blocked coronary arteries to restore blood flow and prevent restenosis.
Over the past two decades, the evolution from bare-metal stents to drug-eluting stents has significantly reduced in-stent restenosis rates and improved long-term patient outcomes. U.S. healthcare providers have rapidly adopted advanced stent technologies, supported by strong FDA regulatory frameworks and clinical trial evidence generated from American cardiovascular research institutions.
The market landscape is shaped by procedure volume trends, reimbursement policies, hospital purchasing contracts, technological differentiation, and clinical guideline updates issued by organizations such as the American College of Cardiology (ACC) and the American Heart Association (AHA). With over one million PCIs performed annually in the U.S., coronary stents remain indispensable devices within cardiac catheterization laboratories.
Key Market Drivers: What’s Fueling the US Coronary Stent Devices Market Growth?
- High Prevalence of Coronary Artery Disease
Coronary artery disease affects millions of Americans, particularly in Southern and Midwestern states such as Kentucky, West Virginia, Mississippi, and Alabama, where cardiovascular mortality rates exceed national averages. Rising obesity, diabetes, smoking, and sedentary lifestyles contribute directly to increased PCI volumes. - Growing Geriatric Population
By 2035, adults aged 65 and older will represent a significantly larger portion of the U.S. population. States such as Florida, Arizona, Pennsylvania, and Maine are experiencing accelerated aging demographics. Older adults exhibit higher risk of coronary blockages, driving sustained stent demand. - Technological Advancements in Drug-Eluting Stents
Second- and third-generation DES platforms utilize improved polymer coatings and antiproliferative drugs to minimize restenosis and thrombosis risks. Thinner strut designs enhance deliverability and reduce vessel injury. - Shift Toward Outpatient PCI
Ambulatory surgical centers in Texas, Georgia, and North Carolina are increasingly performing low-risk elective PCI procedures, supporting steady stent demand. - Favorable Reimbursement and Clinical Guidelines
Medicare and commercial insurance reimbursement coverage for PCI procedures supports consistent adoption of advanced stent technologies nationwide.
Innovation in Focus: How Manufacturers Are Raising the Bar?
Innovation in the U.S. coronary stent market centers on improving long-term safety and procedural efficiency. Manufacturers are focusing on ultrathin strut designs, polymer-free coatings, and bioresorbable materials. Clinical trials conducted in leading U.S. academic centers such as Cleveland Clinic, Mayo Clinic, and Mount Sinai are shaping evidence-based adoption of newer stent platforms.
Artificial intelligence-enabled lesion assessment, advanced imaging integration with IVUS and OCT, and improved radial access compatibility are influencing procedural optimization.
Recent Developments
Recent developments include expanded use of ultrathin strut DES platforms, increased radial access PCI procedures, and integration of IVUS-guided stenting. FDA approvals of next-generation stent technologies are reinforcing market competition. Clinical evidence emphasizing reduced dual antiplatelet therapy duration is shaping product differentiation.
Conclusion
The US Coronary Stent Devices Market Size & Share is projected to expand steadily through 2035, driven by rising cardiovascular disease prevalence, demographic aging, and continuous technological innovation. With strong clinical adoption, supportive reimbursement frameworks, and expanding outpatient PCI volumes, the U.S. remains a highly attractive and innovation-driven coronary stent market.
Key Market Players
- Abbott Laboratories – Illinois-based leader in drug-eluting stents widely used across U.S. cath labs.
- Boston Scientific Corporation – Massachusetts-based manufacturer with strong U.S. DES market share.
- Medtronic plc – Active in coronary stent technologies and U.S. interventional cardiology distribution.
- Terumo Corporation – Supplies interventional devices across U.S. hospitals.
- MicroPort Scientific – Expanding footprint in U.S. coronary device segment.
- Biotronik – Strong presence in high-performance stent platforms.
- B. Braun Medical Inc. – U.S. operations supporting vascular device portfolio.
- Cook Medical – Indiana-based supplier of cardiovascular devices.
- Cordis – Known for legacy coronary stent innovations.
- Edwards Lifesciences – Structural heart expertise influencing catheter-based interventions.
- Shockwave Medical – U.S.-based innovator in intravascular lithotripsy supporting complex PCI.
- Asahi Intecc USA – Guidewire solutions complementing stent procedures.
- Merit Medical Systems – Interventional device supplier.
- Teleflex Incorporated – Vascular access technologies supporting PCI.
- Cardinal Health – Major distributor across U.S. hospital networks.
- GE HealthCare – Imaging systems for cath labs.
- Philips Healthcare – Interventional imaging platforms.
- Siemens Healthineers – Angiography systems integration.
- Stryker Corporation – Expanding cardiovascular portfolio.
- AngioDynamics – Vascular intervention presence.
- Penumbra Inc. – Catheter-based interventional systems.
- Inari Medical – Thrombectomy device innovator.
- Getinge AB – Cath lab infrastructure equipment.
- Haemonetics Corporation – Blood management integration.
- Drug-Eluting Stents dominate the market due to superior long-term clinical outcomes and lower restenosis rates. These stents account for the majority of PCI procedures performed across U.S. hospitals.
- Bare-Metal Stents maintain limited usage in specific patient populations where prolonged dual antiplatelet therapy is contraindicated.
- Bioresorbable Vascular Scaffolds represent an emerging segment, with ongoing clinical evaluation in U.S. research hospitals.
- Cobalt Chromium Stents dominate due to strength and thinner strut capability.
- Platinum Chromium Stents offer enhanced radiopacity and flexibility.
- Stainless Steel Stents remain present but declining in share.
- Polymer-Based Coatings enhance drug delivery and safety.
- Hospitals account for the largest share due to high PCI volume.
- Cardiac Catheterization Laboratories represent core procedural settings.
- Ambulatory Surgical Centers are the fastest-growing segment.
- Specialty Cardiology Clinics contribute selectively in metropolitan areas.
Segmentation By Application
- Stable Angina accounts for substantial elective PCI procedures.
- Acute Coronary Syndrome drives emergency stent demand.
- ST-Elevation Myocardial Infarction requires immediate revascularization.
- Chronic Total Occlusion interventions are increasing with improved technologies.
West Region
The West region dominates revenue share due to advanced healthcare infrastructure in California, Washington, Colorado, Arizona, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.
California leads nationally in PCI volumes due to large population size and extensive hospital networks. Arizona shows rising demand due to elderly migration trends. Washington and Colorado demonstrate strong adoption of advanced DES technologies.
Northeast Region
The Northeast region includes New York, Massachusetts, New Jersey, Pennsylvania, Connecticut, Maine, Vermont, New Hampshire, Rhode Island, and Delaware.
New York represents one of the largest PCI markets due to dense urban population. Massachusetts hosts globally recognized cardiac research centers driving early technology adoption. Pennsylvania and New Jersey exhibit strong hospital-based stent utilization.
South Region (Fastest Growing)
The South region includes Texas, Florida, Georgia, North Carolina, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, and West Virginia.
Texas and Florida contribute significantly due to large population bases and high cardiovascular disease prevalence. Kentucky and West Virginia report among the highest CAD mortality rates, sustaining strong procedural demand.
Midwest Region
The Midwest includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.
Illinois and Ohio maintain large metropolitan hospital networks. Minnesota is home to Mayo Clinic, influencing adoption of innovative stent platforms.
1. US Coronary Stent Devices Market: Market Introduction & Context
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models (2022–2035)
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Manufacturers, Raw Material Suppliers, Hospitals, Cath Labs, ASCs, Distributors, Regulatory Authorities, Payers)
What this section provides:
Defines market scope, methodology, analytical framework, assumptions, and ecosystem participants to establish credibility and transparency.
2. US Coronary Stent Devices Market: Executive Summary
2.1 Key Insights & Market Snapshot (2025 & 2035)
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index
2.4 Strategic Opportunity Assessment
What this section provides:
Highlights market size, CAGR (2026–2035), dominant segments, growth hotspots, and strategic opportunities.
3. US Coronary Stent Devices Market: Market Dynamics & Outlook
3.1 Drivers and their Impact Analysis
3.1.1 Rising Coronary Artery Disease Prevalence
3.1.2 Growing Geriatric Population
3.1.3 Advancements in Drug-Eluting Stent Technologies
3.1.4 Increasing PCI Volumes
3.1.5 Favorable Reimbursement Policies
3.2 Restraints and their Impact Analysis
3.2.1 Pricing Pressure and GPO Contracts
3.2.2 Regulatory Compliance & FDA Approval Timelines
3.2.3 Risk of Stent Thrombosis and Recalls
3.3 Opportunities and their Impact Analysis
3.3.1 Growth of Outpatient PCI & ASCs
3.3.2 Bioresorbable Scaffold Innovation
3.3.3 AI-Integrated Imaging and IVUS/OCT Guidance
3.4 Patent & Innovation Analysis (2020–2025)
What this section provides:
Explains key growth drivers, barriers, innovation patterns, and regulatory trends shaping the market.
4. US Coronary Stent Devices Market: Market Environment & Industry
4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Threat of Substitutes
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Regulatory Framework Analysis (FDA, CMS, ACC/AHA Guidelines)
4.6 Import/Export Restrictions & Tariff Impact
4.7 Government Initiatives on Cardiovascular Care
4.8 Impact of Geopolitical Tensions
What this section provides:
Provides macroeconomic, regulatory, competitive, and supply chain analysis to support strategic decision-making.
5. US Coronary Stent Devices Market – By Product Type
5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.2.1 Drug-Eluting Stents (DES)
5.2.2 Bare-Metal Stents (BMS)
5.2.3 Bioresorbable Vascular Scaffolds
What this section provides:
Analyzes revenue distribution and growth trends across stent types.
6. US Coronary Stent Devices Market – By Material
6.1 Overview
6.2 Segment Share Analysis, By Material, 2025 & 2035 (%)
6.2.1 Cobalt Chromium
6.2.2 Platinum Chromium
6.2.3 Stainless Steel
6.2.4 Polymer-Based Coatings
What this section provides:
Examines material innovation and impact on performance and durability.
7. US Coronary Stent Devices Market – By Application
7.1 Overview
7.2 Segment Share Analysis, By Application, 2025 & 2035 (%)
7.2.1 Stable Angina
7.2.2 Acute Coronary Syndrome
7.2.3 ST-Elevation Myocardial Infarction (STEMI)
7.2.4 Chronic Total Occlusion (CTO)
What this section provides:
Evaluates procedural demand by disease indication.
8. US Coronary Stent Devices Market – By End-User
8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.2.1 Hospitals
8.2.2 Cardiac Catheterization Laboratories
8.2.3 Ambulatory Surgical Centers
8.2.4 Specialty Cardiology Clinics
What this section provides:
Analyzes institutional adoption patterns and purchasing behavior.
9. US Coronary Stent Devices Market – By Geography
9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 West Region Market Size and Forecast (2025–2035)
9.3.3 West Region Market Size by Product Type
9.3.4 West Region Market Size by Material
9.3.5 West Region Market Size by Application
9.3.6 West Region Market Size by End-User
9.3.7 California
9.3.8 Washington
9.3.9 Colorado
9.3.10 Arizona
9.3.11 Oregon
9.3.12 Utah
9.3.13 Nevada
9.3.14 New Mexico
9.3.15 Idaho
9.3.16 Montana
9.3.17 Wyoming
9.3.18 Alaska
9.3.19 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut
9.4.7 Maine
9.4.8 Vermont
9.4.9 New Hampshire
9.4.10 Rhode Island
9.4.11 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama
9.5.9 Mississippi
9.5.10 Louisiana
9.5.11 Arkansas
9.5.12 Kentucky
9.5.13 Oklahoma
9.5.14 Maryland
9.5.15 Virginia
9.5.16 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri
9.6.9 Iowa
9.6.10 Kansas
9.6.11 Nebraska
9.6.12 North Dakota
9.6.13 South Dakota
What this section provides:
State-level revenue forecasts, cardiovascular burden analysis, cath lab density insights, and growth hotspot identification.
10. US Coronary Stent Devices Market: Competitive Landscape & Company Profiles
10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Abbott Laboratories
10.3.2 Boston Scientific Corporation
10.3.3 Medtronic plc
10.3.4 Terumo Corporation
10.3.5 Biotronik
10.3.6 MicroPort Scientific Corporation
10.3.7 B. Braun Medical Inc.
10.3.8 Cook Medical
10.3.9 Cordis
10.3.10 Edwards Lifesciences
10.3.11 Shockwave Medical
10.3.12 Asahi Intecc USA
10.3.13 Merit Medical Systems
10.3.14 Teleflex Incorporated
10.3.15 Cardinal Health
10.3.16 Siemens Healthineers
10.3.17 GE HealthCare
10.3.18 Philips Healthcare
10.3.19 Stryker Corporation
10.3.20 AngioDynamics
10.3.21 Penumbra Inc.
10.3.22 Inari Medical
10.3.23 Getinge AB
10.3.24 Haemonetics Corporation
What this section provides:
Detailed competitive benchmarking including company overview, U.S. footprint, product portfolio, and strategic developments.
11. US Coronary Stent Devices Market: Future Market Outlook (2025–2035)
11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Disruptive Technologies Impact
11.3 Emerging Business Trends
11.4 Investment Opportunities
What this section provides:
Long-term projections and strategic outlook for stakeholders.
12. US Coronary Stent Devices Market: Strategic Recommendations
What this section provides:
Actionable recommendations for manufacturers, providers, investors, and policymakers.
13. US Coronary Stent Devices Market: Disclaimer
What this section provides:
Legal boundaries, data limitations, and usage terms of the report.
List of Tables
TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Coronary Stent Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Coronary Stent Devices Market: Material Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Material
TABLE 9: US Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 10: US Coronary Stent Devices Market: Application Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Application
TABLE 12: US Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 13: US Coronary Stent Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Coronary Stent Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Coronary Stent Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 21: California Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 22: California Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 25: Washington Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 26: Washington Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 29: Colorado Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 30: Colorado Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 33: Arizona Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 34: Arizona Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 37: Oregon Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 38: Oregon Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 41: West – Others Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 42: West – Others Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 45: New York Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 46: New York Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 49: Massachusetts Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 50: Massachusetts Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 53: New Jersey Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 54: New Jersey Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 61: Connecticut Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 62: Connecticut Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 69: Texas Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 70: Texas Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 73: Florida Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 74: Florida Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 77: Georgia Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 78: Georgia Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 81: North Carolina Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 82: North Carolina Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 85: Tennessee Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 86: Tennessee Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 89: South Carolina Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 90: South Carolina Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 93: Alabama Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 94: Alabama Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 97: South – Others Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 98: South – Others Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 101: Illinois Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 102: Illinois Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 105: Ohio Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 106: Ohio Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 109: Michigan Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 110: Michigan Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 113: Minnesota Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 114: Minnesota Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 117: Indiana Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 118: Indiana Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 121: Wisconsin Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 122: Wisconsin Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 125: Missouri Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 126: Missouri Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Coronary Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Coronary Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Coronary Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Coronary Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)
List of Figures
FIGURE 1: US Coronary Stent Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Material Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Material Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Application Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Coronary Stent Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Coronary Stent Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Coronary Stent Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Coronary Stent Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Coronary Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
